Cargando…

Multivariate prediction of dementia in Parkinson’s disease

Cognitive impairment in Parkinson’s disease (PD) is pervasive with potentially devastating effects. Identification of those at risk for cognitive decline is vital to identify and implement appropriate interventions. Robust multivariate approaches, including fixed-effect, mixed-effect, and multitask...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phongpreecha, Thanaphong, Cholerton, Brenna, Mata, Ignacio F., Zabetian, Cyrus P., Poston, Kathleen L., Aghaeepour, Nima, Tian, Lu, Quinn, Joseph F., Chung, Kathryn A., Hiller, Amie L., Hu, Shu-Ching, Edwards, Karen L., Montine, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447766/ https://www.ncbi.nlm.nih.gov/pubmed/32885039 http://dx.doi.org/10.1038/s41531-020-00121-2

Ejemplares similares

Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2022)

Gait and balance in apolipoprotein Ɛ4 allele carriers in older adults and Parkinson’s disease
por: Morris, Rosie, et al.
Publicado: (2023)

Single-cell peripheral immunoprofiling of Alzheimer’s and Parkinson’s diseases
por: Phongpreecha, Thanaphong, et al.
Publicado: (2020)

Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
por: Kim, Hojoong M., et al.
Publicado: (2019)

Quantitative estimate of cognitive resilience and its medical and genetic associations
por: Phongpreecha, Thanaphong, et al.
Publicado: (2023)

Resting-State Cerebello-Cortical Dysfunction in Parkinson's Disease
por: Palmer, William C., et al.
Publicado: (2021)

Sensorimotor Inhibition and Mobility in Genetic Subgroups of Parkinson's Disease
por: Martini, Douglas N., et al.
Publicado: (2020)

White Matter Hyperintensities Related to Parkinson's Disease Executive Function
por: Linortner, Patricia, et al.
Publicado: (2020)

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
por: Cholerton, Brenna, et al.
Publicado: (2016)

Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE
por: Phongpreecha, Thanaphong, et al.
Publicado: (2021)

Whole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
por: Berson, Eloise, et al.
Publicado: (2023)

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Cross-species comparative analysis of single presynapses
por: Berson, Eloïse, et al.
Publicado: (2023)

Systematic Immunophenotyping Reveals Sex-Specific Responses After Painful Injury in Mice
por: Tawfik, Vivianne L., et al.
Publicado: (2020)

A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?
por: Hiller, Amie L., et al.
Publicado: (2018)

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
por: Cooper, Christine A., et al.
Publicado: (2016)

Association Between the Ubiquitin Carboxyl-Terminal Esterase L1 Gene (UCHL1) S18Y Variant and Parkinson's Disease: A HuGE Review and Meta-Analysis
por: Ragland, Margaret, et al.
Publicado: (2009)

The RAB39B p.G192R mutation causes X-linked dominant Parkinson’s disease
por: Mata, Ignacio F., et al.
Publicado: (2015)

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
por: Montine, Thomas J., et al.
Publicado: (2015)

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
por: Tumas, Vitor, et al.
Publicado: (2016)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011)

Objective Activity Parameters Track Patient-specific Physical Recovery Trajectories After Surgery and Link With Individual Preoperative Immune States
por: Fallahzadeh, Ramin, et al.
Publicado: (2023)

Concepts for brain aging: resistance, resilience, reserve, and compensation
por: Montine, Thomas J., et al.
Publicado: (2019)

Deep representation learning identifies associations between physical activity and sleep patterns during pregnancy and prematurity
por: Ravindra, Neal G., et al.
Publicado: (2023)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

A data-driven health index for neonatal morbidities
por: De Francesco, Davide, et al.
Publicado: (2022)

What light have resting state fMRI studies shed on cognition and mood in Parkinson’s disease?
por: YorkWilliams, Sophie, et al.
Publicado: (2014)

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
por: Lin, Xiangmin, et al.
Publicado: (2012)

Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
por: Hill-Burns, Erin M., et al.
Publicado: (2011)

PNPLA6‐Related Disorder with Levodopa‐Responsive Parkinsonism
por: Kazanci, Serdar, et al.
Publicado: (2022)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Mnemonic Similarity Task to study episodic memory in Parkinson's disease
por: Das, Tanusree, et al.
Publicado: (2020)

Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel
por: Sabbagh, Marwan N., et al.
Publicado: (2023)

Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease
por: Wallen, Zachary D., et al.
Publicado: (2018)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Identification of a novel Parkinson’s disease locus via stratified genome-wide association study
por: Hill-Burns, Erin M, et al.
Publicado: (2014)

Letter to the Editor: Hypothesis: Somatic Mosaicism and Parkinson Disease
por: Perandones, C, et al.
Publicado: (2015)

Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease
por: Hamza, Taye H., et al.
Publicado: (2014)

Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
por: Gasca-Salas, Carmen, et al.
Publicado: (2021)

Distinct alterations in Parkinson's medication-state and disease-state connectivity
por: Ng, Bernard, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vdpld293d8jgcf7kae7tms5kak